EGFR and non-small cell lung carcinoma: These findings offer valuable insights into how EGFR-mutated non-small-cell lung cancer is managed in everyday practice, highlighting differences in outcomes that could inform future research, enhance clinical guidelines, and support more personalized treatment decisions in real-world settings.